Nexium RESPONSE Trial
Study identifier:D9612L00076
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Development of an Algorithm for Identification of Responders to Short Term Treatment with Esomeprazole (Nexium) in Primary Care
Medical condition
GERD
Phase
Phase 4
Healthy volunteers
No
Study drug
Esomeprazole
Sex
All
Actual Enrollment
1000
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 May 2006
Primary Completion Date: -
Study Completion Date: 01 Nov 2007
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Diagnostic
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Villy Meineche Schmidt
Charlottenlund Research Site
